Home » Newsletters » BioWorld Science

BioWorld Science

March 31, 2009

View Archived Issues

Clinical studies reveal efficacy of bepotastine in treating allergic conjunctivitis

Fourth quarter highlights at Merck KGaA

Novel substituted tetrahydronaphthalines claimed by sanofi-aventis

Novel b-Raf inhibitors claimed by Takeda

Agile signs clinical trial agreement for its progestin-only contraceptive patch AG-1000

FDA issues complete response letter to Dyax regarding BLA for DX-88 in HAE

Biogen Idec reports favorable interim results from phase IIa studies of BIIB-014 in PD

Infinity initiates phase II IPI-504 trial in HER2-positive breast cancer

Faron presents update on its lead compoumd Traumakine

FDA clears Curemark's IND for phase III clinical trial of CM-AT in autism

reMYND presents first-in-class drug candidates for Alzheimer's, Parkinson's disease

Oral MC-4 receptor antagonists developed by Santhera for cachexia

Novel compounds for the treatment of mood disorders presented by GlaxoSmithKline

Boehringer Ingelheim claims the discovery of novel arylsulfonamides with analgesic activity

Novel phosphodiesterase type 10 inhibitors claimed by Amgen

Portola Pharmaceuticals describes second-generation P2Y12 inhibitors

Dual specificity antibody displays in vitro and in vivo antiproliferative activity

Tadalafil improves benign prostatic hyperplasia symptoms regardless of erectile function status

Archemix initiates phase IIa ARC-1779 trial

EffRx signs expansion of licensing deal with Nycomed for EX-101

AstraZeneca to meet with FDA Psychopharmacologic Drugs Advisory Committee

Seattle Genetics receives FDA fast track for SGN-35 for Hodgkin's lymphoma

Arena reports pivotal phase III results for lorcaserin in obesity

PharmaMar and Taiho sign license agreement for antitumor drug Yondelis in Japan

Ixiaro vaccine receives FDA approval for Japanese encephalitis prevention

FDA approves Afinitor in patients with advanced kidney cancer

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...